IR News

YOU ARE OBLIGED TO CAREFULLY READ THE FOLLOWING TERMS AND CONDITIONS UNDER WHICH YOU ARE BEING GRANTED ACCESS TO THE DOCUMENTS AND INFORMATION CONTAINED IN THE FOLLOWING PART OF THE WEBSITE.

THE INFORMATION CONTAINED IN THE FOLLOWING PART OF THE WEBSITE DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE OR A SOLICITATION TO MAKE AN OFFER TO PURCHASE SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION OR TO ANY PERSON TO THE EXTENT SUCH OFFER OR SOLICITATION IS PROHIBITED OR NOT AUTHORIZED.

No money, securities, or other consideration is being solicited through this part of the website.

In some countries, in particular in the United States of America, Canada, Japan and Australia, the dissemination of this information may be restricted or prohibited under applicable law. The users of this part of the website are required to inform themselves of and comply with any such restrictions.

For the reasons stated above, you are requested to enter the following data:

Permission denied

Due to applicable legal restrictions, we are unable to provide you with access to this section of the website of Marinomed Biotech AG. Please click here to return to the Investors website.


Share
Contact
Marinomed Biotech AG
Veterinärplatz 1
1210 Vienna, Austria
Telefon: +43 1 25077 4460
Fax: +43 1 25077 4493
Email: office@marinomed.com